Article
Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms.
Platelets - 1 Nov 2018
Perrier-Cornet Andréas, Ianotto Jean-Christophe, Mingant Fanny, Perrot Maëla, Lippert Eric, Galinat Hubert
Abstract excerpt
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis. Aspirin is recommended to reduce this risk, but resistance to antiplatelet therapy seems to hamper its efficacy in some patients. We have previously shown that multiple electrode aggregometry (MEA) was a valuable tool to assess aspirin resistance in MPN. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
